Year: 2019

Orchard Therapeutics Announces the Filing and Validation of Marketing Authorization Application by European Medicines Agency for OTL-200 for the Treatment of Metachromatic Leukodystrophy

Written by Customer Service on December 2, 2019. Posted in Public Companies.

BOSTON and LONDON, Dec. 02, 2019 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, today announced that the European Medicines Agency (EMA) has validated the company’s Marketing Authorization Application (MAA) for OTL-200, an ex vivo, autologous, hematopoietic stem cell-based gene therapy that has been developed in partnership with the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, for the treatment of metachromatic leukodystrophy (MLD). Validation of the MAA confirms that the submission is sufficiently complete to begin the formal review process.“We are pleased that OTL-200 for the treatment of MLD is now under review...

Invesco Ltd.: Form 8.3 – Redde PLC

Written by Customer Service on December 2, 2019. Posted in Mergers And Acquisitions.

Opening Position DisclosureFORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant...

ChromaDex Receives Approval for Nicotinamide Riboside Chloride as an Ingredient for Complementary Medicines from the Australian Therapeutic Goods Administration (TGA)

Written by Customer Service on December 2, 2019. Posted in Public Companies.

LOS ANGELES, Dec. 02, 2019 (GLOBE NEWSWIRE) — ChromaDex Corp. (NASDAQ:CDXC) today announced that it has received approval from the Australian Therapeutic Goods Administration (TGA) for its patented nicotinamide riboside chloride (NR) for use in listed complementary medicines. The listing indicates that ChromaDex has market exclusivity of NR through December 2, 2021.With this approval, ChromaDex will be listing their final product as a complementary medicine on the Australian Register of Therapeutic Goods (ARTG).“This is an important milestone as we expand our presence in the Asia-Pacific region,” says ChromaDex CEO Rob Fried. “We look forward to sharing the unparalleled science behind our ingredient with the people of Australia in 2020.”Cells can use NR to create nicotinamide adenine dinucleotide (NAD), which is an essential molecule...

Enthusiast Gaming Announces Pro Forma Revenue of $6.3 Million in Third Quarter 2019

Written by Customer Service on December 2, 2019. Posted in Public Companies.

Completes mergers of Enthusiast Gaming, Aquilini GameCo, and Luminosity Gaming in Q3 to create leading publicly traded esports and gaming organization Filed interim financial statements for the three and nine month periods ending September 30, 2019, with revenue of $3.0 million being reported relating to the post merger period of August 27 to September 30, 2019Assuming the completion of the Enthusiast, Aquilini GameCo, and Luminosity Gaming mergers retrospectively to July 1, 2019, pro forma revenue for Q3 2019 would be $6.3 millionAchieves pro forma consolidated gross margins of 49% in the quarterCompletes the funding of the Deferred Payment on “The Sims Resource” acquisition, seven months ahead of scheduleTORONTO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (TSXV: EGLX) (FSE: 2AV) (“Enthusiast Gaming”...

Uxin Announces the Resignation of Chief Strategy Officer

Written by Customer Service on December 2, 2019. Posted in Public Companies.

BEIJING, Dec. 02, 2019 (GLOBE NEWSWIRE) — Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), a leading national online used car dealer in China, today announced that Mr. Wenbing Jing has resigned as the Company’s Chief Strategy Officer, effective December 1, 2019, for personal reasons. During his tenure with the Company, Mr. Jing mainly oversaw the Company’s loan facilitation business, which is currently in the process of being divested as announced by the Company in July, September and November 2019.Mr. Kun Dai, Founder, Chairman and Chief Executive Officer of Uxin, said, “Wenbing has been a long-time friend and trusted partner and helped drive the fast growth of our business over the past several years. We sincerely appreciate Wenbing’s contributions and dedication to the Company and wish him the best in his future endeavors.”About...

New Look Vision Group Inc. Enters US Optical Retail With the Acquisition of Edward Beiner in Florida

Written by Customer Service on December 2, 2019. Posted in Public Companies.

MONTREAL, Dec. 02, 2019 (GLOBE NEWSWIRE) — New Look Vision Group Inc. (“New Look Vision”) (TSX: BCI), Canada’s largest optical company, announced today that it has entered into a definitive agreement to acquire substantially all of the assets of Miami based Coco Lunette Holding, LLC which carries on business principally under the Edward Beiner banner (the “Edward Beiner Company”). Known for its unique and original designer eyewear, over the years under the direction of Edward Beiner and Guido Balocco, the Edward Beiner Company has built a strong presence in key premium markets across 12 locations in Florida including Miami, Aventura, Boca Raton, Coconut Grove, Coral Gables, Naples, Orlando and Palm Beach. Its current annualized revenues are $15.5 million Cdn and it will continue to operate as a stand-alone unit within the New...

Groupe Vision New Look Inc. perce le marché américain de la vente au détail de lunettes en faisant l’acquisition d’Edward Beiner en Floride

Written by Customer Service on December 2, 2019. Posted in Public Companies.

MONTRÉAL, 02 déc. 2019 (GLOBE NEWSWIRE) — Groupe Vision New Look Inc. (« Vision New Look ») (TSX: BCI) – la plus importante entreprise de produits et services de l’optique au Canada – annonçait plus tôt aujourd’hui qu’elle venait de conclure une entente définitive visant à faire l’acquisition de la quasi-totalité des actifs de Coco Lunette Holding, LLC de Miami, qui exerce ses activités principalement sous la bannière d’Edward Beiner (« entreprise Edward Beiner »). Reconnue pour ses lunettes de designer uniques et originales, et sous la direction d’Edward Beiner et Guido Balocco, l’entreprise Edward Beiner s’est imposée au fil des ans à travers 12 boutiques dans les principaux marchés de luxe de la Floride, tels que Miami, Aventura, Boca Raton, Coconut Grove, Coral Gables, Naples, Orlando et Palm Beach. Avec des revenus annualisés...

Sprout Social Announces Launch of Initial Public Offering

Written by Customer Service on December 2, 2019. Posted in Public Companies.

CHICAGO, Dec. 02, 2019 (GLOBE NEWSWIRE) — Sprout Social, Inc. (“Sprout Social” or the “Company”) announced today the launch of its initial public offering of 8,823,530 shares of Class A common stock. The initial public offering price is expected to be between $16.00 and $18.00 per share, before underwriting discounts and commissions. In addition, the Company expects to grant the underwriters a 30-day option to purchase up to an additional 1,323,529 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions. Sprout Social’s existing stockholders will not sell any shares in the offering. The Company has applied to list its shares of Class A common stock on the Nasdaq Global Market under the symbol “SPT.”The Company intends to use the gross proceeds from the offering for working capital...

Brim: Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun

Written by Customer Service on December 2, 2019. Posted in Public Companies.

Í viku 48 keypti Brim hf. 5.150.000 eigin hluti að kaupverði 197.802.500 kr. skv. sundurliðun hér á eftir:Viðskiptin eru samkvæmt endurkaupaáætlun félagsins sem tilkynnt var um í Kauphöll þann 26. september 2019.Brim átti 39.655.095 eigin hluti fyrir viðskiptin og eiga að þeim loknum 44.805.095 eigin hluti eða sem nemur 2,291% af útgefnum hlutum í félaginu.Þann 21.10.2019 var tillkynnt um að Brim hefði gert samning um kaup á tveimur sjávarútvegsfyrirtækjum, stjórn Brims samþykkti kaupin þann 14.11.2019. Viðskiptin eru háð samþykki hluthafafundar Brims, Samkeppniseftirlitsins og eftir atvikum annara eftirlitsaðila. Hluthafafundur Brims hefur verið boðaður þann 12. desember n.k.. Hluti kaupverðsins verði greiddur með eigin bréfum að nafnverði 22.079.436 eða 1,13% af heildarhlutafé.Brim hefur keypt samtals 36.235.818 eigin hluti samkvæmt...

Registration of Tranche One Private Placement in IDEX Biometrics

Written by Customer Service on December 2, 2019. Posted in Public Companies.

Reference is made to the notice on 18 November 2019 about a private placement of 120 million shares, raising NOK 90 million (USD 10 million). Tranche One of the share capital increase, 55,425,407shares has been registered and the shares will be delivered soonest. The company’s share capital is NOK 98,012,120.85 divided into 653,414,139 shares each with a nominal value of NOK 0.15.2 Decenber 2019IDEX Biometrics ASAFor further information contact:Derek P. D’Antilio, CPA;Chief Financial OfficerTel: +1 978 273 1344derek.dantilio@idexbiometrics.comErling SvelaVP FinanceTel: +47 4062 1040erling.svela@idexbiometrics.comAbout IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments,...

Year: 2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals